Keyphrases
Renal Cell Carcinoma
100%
Interleukin-2
100%
Metastatic Melanoma
100%
Adoptive Immunotherapy
100%
Human Melanoma Cells
100%
Tumor-infiltrating Lymphocytes
100%
Non-responders
30%
Moderate Dose
20%
No Response
20%
Tumor Necrosis Factor-α
10%
Patient-completed
10%
Interleukin-6
10%
High Dose
10%
Biopsy Specimen
10%
Maximum Tolerated Dose
10%
Granulocyte Colony-stimulating Factor (G-CSF)
10%
Cytotoxic Activity
10%
Redirected Lysis
10%
Interleukin-4 (IL-4)
10%
Durable Response
10%
Progressive Disease
10%
Cytotoxicity
10%
Interferon-γ
10%
Human Tumor Cells
10%
Melanoma Cells
10%
Melanoma Patients
10%
Melanoma
10%
Melanocytic Tumor
10%
OKT3
10%
Complete Tumor Regression
10%
Anti-CD3 Antibody
10%
Immunogenic Tumor
10%
Alpha4
10%
Lymphocyte Culture
10%
Human interleukin-2
10%
Nursing and Health Professions
Neoplasm
100%
Pilot Study
100%
Interleukin 2
100%
Adoptive Immunotherapy
100%
Melanoma
100%
Renal Cell Carcinoma
100%
Metastatic Melanoma
16%
Tumor Regression
8%
Drug Megadose
8%
Maximum Permissible Dose
8%
Tumor Necrosis Factor
8%
Interleukin 6
8%
Immunotherapy
8%
Alanine
8%
Biopsy Technique
8%
Gamma Interferon
8%
Interleukin 4
8%
Lymphocyte Culture
8%
CD3 Antibody
8%
Granulocyte Macrophage Colony Stimulating Factor
8%
Diseases
8%
Medicine and Dentistry
Clear Cell Renal Cell Carcinoma
100%
Interleukin 2
100%
Adoptive Immunotherapy
100%
Tumor Infiltrating Lymphocyte
100%
Melanoma
100%
Cytotoxicity
20%
Metastatic Melanoma
20%
Tumor Necrosis Factor
10%
Health Care Cost
10%
Neoplasm
10%
Immunotherapy
10%
Interleukin 6
10%
Drug Megadose
10%
Progressive Disease
10%
Alanine
10%
Tumor Regression
10%
Interleukin 4
10%
Gamma Interferon
10%
Biopsy Technique
10%
Granulocyte Macrophage Colony Stimulating Factor
10%
Recombinant
10%
Autologous Tumor Cell
10%
CD3 Antibody
10%
Lymphocyte Culture
10%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Renal Cell Carcinoma
100%
Melanoma
100%
Immunotherapy
100%
Interleukin 2
100%
Metastatic Melanoma
16%
Cytotoxicity
16%
Tumor Necrosis Factor
8%
Granulocyte Macrophage Colony Stimulating Factor
8%
Interleukin 6
8%
Alanine
8%
Gamma Interferon
8%
Recombinant
8%
Tumor Regression
8%
Interleukin 4
8%
CD3 Antibody
8%
Diseases
8%
Immunology and Microbiology
Carcinoma Cell
100%
Interleukin 2
100%
Adoptive Immunotherapy
100%
Tumor-Infiltrating Lymphocytes
100%
Cytotoxicity
20%
Drug Megadose
10%
Tumor Cell
10%
Interleukin 6
10%
Immunotherapy
10%
Interleukin 4
10%
Granulocyte Macrophage Colony-Stimulating Factor
10%
Tumor Necrosis Factor Alpha
10%
Interferon Gamma
10%
Maximum Permissible Dose
10%
CD3 Antibody
10%
Alanine
10%
Veterinary Science and Veterinary Medicine
Renal Cell Carcinoma
100%